title: [Contraconception in women with systemic lupus erythematosus].
authors.affiliation: Departamento de Biología de la Reproducción, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, México D.F. mcravioa@quetzal.innsz.mx
authors.forename: María del Carmen
authors.initials: Mdel C
authors.lastname: Cravioto
authors.forename: Marta
authors.initials: M
authors.lastname: Durand-Carbajal
authors.forename: Jorge
authors.initials: J
authors.lastname: Sánchez-Guerrero
mesh_terms: D000328:Adult; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized; D016736:Antiphospholipid Syndrome / Q000150:complications; D003267:Contraception / Q000379:methods*; D042121:Contraception, Barrier; D003277:Contraceptives, Oral, Combined / Q000009:adverse effects / Q000494:pharmacology; D003278:Contraceptives, Oral, Hormonal / Q000009:adverse effects / Q000494:pharmacology; D000075202:Contraindications; D005260:Female; D012739:Gonadal Steroid Hormones / Q000009:adverse effects / Q000378:metabolism; D006801:Humans; D007435:Intrauterine Devices, Copper; D007436:Intrauterine Devices, Medicated / Q000009:adverse effects; D016912:Levonorgestrel / Q000009:adverse effects; D008180:Lupus Erythematosus, Systemic / Q000150:complications / Q000188:drug therapy / Q000378:metabolism; D017410:Practice Guidelines as Topic; D011247:Pregnancy; D018566:Pregnancy, High-Risk; D011372:Progestins / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology; D019851:Thrombophilia / Q000139:chemically induced / Q000209:etiology
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D003277:Contraceptives, Oral, Combined; D003278:Contraceptives, Oral, Hormonal; D012739:Gonadal Steroid Hormones; D011372:Progestins; D016912:Levonorgestrel; C511911:belimumab